Brotons Pedro, Saucedo Jesica, Simó Silvia, Gené Amadeu, Muñoz-Almagro Carmen
From the Institut de Recerca Sant Joan de Deu, Barcelona, Spain.
CIBER de Epidemiología y Salud Pública CIBERESP, Madrid, Spain.
Pediatr Infect Dis J. 2021 Feb 1;40(2):169-172. doi: 10.1097/INF.0000000000002907.
We aimed to evaluate diagnostic performance of the cobas® Liat® Cdiff test, a novel single-step automated polymerase chain reaction (PCR) assay for rapid diagnosis of toxigenic Clostridioides difficile infection (CDI) in stool samples from children with clinical symptoms of CDI.
Assessment of cobas Liat Cdiff diagnostic yield, time of analytical process and agreement of results with those of a 2-step diagnostic algorithm. The sequential algorithm combined an enzyme immunoassay (EIA) targeting antigen glutamate dehydrogenase (GDH), enterotoxin-A and cytotoxin-B, and a confirmatory PCR in EIA GDH-positive and toxin-negative samples. Fresh stool samples were collected prospectively from patients 2-18 years of age that were attended in Hospital Sant Joan de Deu (Barcelona, Spain) during December 2018-August 2019.
A total of 122 specimens were collected from 91 children (mean age, 8 years; 69.7% male). cobas Liat Cdiff identified 24 (19.7%) positive samples. EIA yielded 97 (79.5%) GDH- and toxin-negative results, 11 (9.0%) GDH- and toxin-positive results, and 14 (11.5%) GDH-positive and toxin-negative results, of which 11 (9.0%) were positive for the toxin by the confirmatory PCR. Overall, GDH- and toxin-positive samples detected by the sequential algorithm were 22 (18.0%). Comparatively, the new test reduced time of the analytical process significantly (20 vs. 35.4 minutes, P < 0.001).
Use of cobas Liat Cdiff showed similar detection yield compared with a 2-step diagnostic algorithm that combined an EIA and a confirmatory PCR while decreasing the time of the analytical process markedly in stool samples from children suspected of CDI.
我们旨在评估 cobas® Liat® Cdiff 检测的诊断性能,这是一种新型的单步自动化聚合酶链反应(PCR)检测方法,用于快速诊断有艰难梭菌感染(CDI)临床症状的儿童粪便样本中的产毒艰难梭菌感染。
评估 cobas Liat Cdiff 的诊断率、分析过程时间以及结果与两步诊断算法结果的一致性。该序贯算法结合了针对抗原谷氨酸脱氢酶(GDH)、肠毒素 A 和细胞毒素 B 的酶免疫测定(EIA),以及对 EIA GDH 阳性且毒素阴性样本进行的验证性 PCR。2018 年 12 月至 2019 年 8 月期间,前瞻性地从西班牙巴塞罗那圣琼德迪乌医院就诊的 2 - 18 岁患者中收集新鲜粪便样本。
共从 91 名儿童(平均年龄 8 岁;69.7%为男性)中收集了 122 份标本。cobas Liat Cdiff 鉴定出 24 份(19.7%)阳性样本。EIA 得出 97 份(79.5%)GDH 和毒素阴性结果、11 份(9.0%)GDH 和毒素阳性结果以及 14 份(11.5%)GDH 阳性且毒素阴性结果,其中 11 份(9.0%)经验证性 PCR 检测毒素呈阳性。总体而言,序贯算法检测到的 GDH 和毒素阳性样本为 22 份(18.0%)。相比之下,新检测方法显著缩短了分析过程时间(20 分钟对 35.4 分钟,P < 0.001)。
与结合 EIA 和验证性 PCR 的两步诊断算法相比,使用 cobas Liat Cdiff 在疑似 CDI 的儿童粪便样本中显示出相似的检测率,同时显著缩短了分析过程时间。